Voriconazole Powder, For Suspension
Product Images NDC 70436-230

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 70436-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure diagram of voriconazole, showing its molecular arrangement including fluorinated aromatic rings and heterocyclic components.*
FDA Label Image

Picture1 (Image 02)

Picture1 (Image 02)
An illustration showing components of an oral suspension packaging for voriconazole powder. It depicts a bottle with a child-resistant bottle cap, a bottle adapter, and an oral dispenser consisting of a plunger, tip, and graduated dispenser syringe for precise dosing.*
FDA Label Image

Picture2 (Image 03)

Picture2 (Image 03)
Instructional illustration showing a person's hands grasping a bottle and turning the cap clockwise, indicating how to open or close the bottle containing voriconazole powder for suspension.*
FDA Label Image

Picture3 (Image 04)

Picture3 (Image 04)
An instructional illustration showing hands holding a bottle with a stopper. Arrows indicate pressing down on the stopper, suggesting a step in opening or sealing the bottle.*
FDA Label Image

Picture4 (Image 05)

Picture4 (Image 05)
An illustration showing the top view of a bottle with a child-resistant closure. The bottle appears to be partially filled with liquid, representing a container likely used for oral suspension medications such as voriconazole powder for suspension.*
FDA Label Image

Picture5 (Image 06)

Picture5 (Image 06)
An illustration showing hands preparing a single-dose oral syringe device by pressing down on the plunger. The image demonstrates the step of depressing the plunger, indicated by a downward arrow, for administration of an oral suspension.*
FDA Label Image

Picture6 (Image 07)

Picture6 (Image 07)
An instructional black-and-white illustration showing a hand using a dosing syringe to withdraw liquid medication from an open bottle. The image demonstrates the proper method for drawing up oral suspension medication, relevant to voriconazole 40 mg/mL powder for suspension by Slate Run Pharmaceuticals.*
FDA Label Image

Picture7 (Image 08)

Picture7 (Image 08)
An instructional line drawing showing a hand inserting a measuring device into the opening of a bottle. The image demonstrates the proper technique for drawing liquid from the container, suggesting measurement or administration of an oral suspension.*
FDA Label Image

Picture8 (Image 09)

Picture8 (Image 09)
An instructional illustration showing two hands preparing an oral liquid dose using a syringe. One hand holds a bottle upside down, while the other hand pulls the plunger of a syringe attached to the bottle's opening, with an arrow indicating downward movement, suggesting liquid is being drawn into the syringe.*
FDA Label Image

Picture9 (Image 10)

Picture9 (Image 10)
An instructional illustration showing a hand using a syringe to withdraw liquid medication from an open bottle. The syringe is inserted into the bottle's opening, demonstrating proper technique for drawing liquid from the vial.*
FDA Label Image

Picture10 (Image 11)

Picture10 (Image 11)
An instructional illustration showing a person's hands opening a child-resistant cap on a bottle, likely demonstrating how to twist the cap to remove it. The bottle contains a liquid or suspension, consistent with oral medication packaging.*
FDA Label Image

40 mg/ml Bottle Label (Image 12)

40 mg/ml Bottle Label (Image 12)
Voriconazole for Oral Suspension, 40 mg/mL strength, powder for suspension for oral use. The label indicates the product is orange flavored with a 75 mL volume after reconstitution. Manufactured by Zhejiang Poly Pharm Co., Ltd. and distributed by Slate Run Pharmaceuticals, LLC. Directions for storage and mixing are provided, along with a barcode and space for reconstitution date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.